Skip to content

Investors have limited time left: Only 5 days remain for Allianz and BASF

Stock market investors aiming for lucrative returns in 2025 should consider a blend of momentum and turnaround stocks, with Allianz and BASF potentially benefitting from prompt actions.

Investors aiming for substantial gains in the stock market by 2025 are advised to strategically...
Investors aiming for substantial gains in the stock market by 2025 are advised to strategically combine momentum and turnaround stocks. Urgent consideration of Allianz and BASF is recommended due to their potential growth prospects.

Investors have limited time left: Only 5 days remain for Allianz and BASF

Stock Powerhouses for 2025: Allianz and BASF - Here's Why

In the thriving world of stock trading, investors eyeing big bucks in 2025 should focus on a strategic mix of momentum stocks and turnaround prospects, such as Allianz and BASF. Here's a lowdown on why these stocks are worth a shot.

Allianz: The Momentum Maker

Allianz, with its accelerating performance, offers a lucrative dividend of 5.46% and promises further hikes. The financial powerhouse has been increasing its payout by an average of 8.92% yearly over the past five years, making it an appealing choice for long-term investors.

With a P/E ratio of 11.1, Allianz is a steal, and analysts anticipate a rise in earnings per share from 24.99 euros to 27.30 euros in 2025. Deutsche Bank Research has upgraded the Allianz stock to 329 euros after the capital market day, maintaining its "Buy" rating. The company's financial figures remain robust, and the stock continues its uptrend, signaling a potential breakthrough of the 304 euro mark. The BOERSE ONLINE team recommends buying Allianz, with a price target set at 350 euros.

BASF: A promising Turnaround Candidate

While BASF has been skirting the edge of a breakout, investors should keep a keen eye as the company's recovery could be right around the corner. Investors will want to see the stock maintain a minimum of 42 euros to avoid a downward spiral.

Recent optimistic analyst comments and an improved outlook for 2025 have given investors renewed hope. Warburg Research, for instance, upgraded BASF from "Hold" to "Buy" and increased its price target from 51.00 to 52.60 euros. The BOERSE ONLINE team predicts a turnaround for BASF, setting the target at 65 euros and recommending a buy.

Given the uncertainty surrounding BASF's recovery, a prudent approach would be to invest two-thirds of new funds in the momentum stock Allianz and the remaining third in the turnaround candidate BASF.

Remember, the BOERSE ONLINE Global Dividend Stars Index presents a multitude of exciting dividend stocks to explore.

The Bottom Line

Both Allianz and BASF present appealing investment opportunities due to their market positions and potential for strategic growth. With Allianz offering a forward dividend yield of approximately 4.19%, and BASF approaching full free cash flow coverage of its dividend by 2026 with a cash-backed implied dividend yield of about 5.5% in that year, these stocks are worthy considerations for your 2025 portfolio.

[1] BASF Stock: The Beauty of German Engineering

[2] Top 3 European Stocks to Own for High Dividends

[3] Allianz: A Safety Net Amid Rising Market Volatility

[4] BASF SE: A Beacon of Stability Amidst Crisis

[5] BASF to Divest Coatings Business, Possible Value Unlock

  1. For investors seeking high dividends and strategic growth in 2025, Allianz and BASF are promising choices, especially considering Allianz's momentum as a lucrative dividend stock with an expected 5.46% dividend and potential rise in earnings per share, and BASF's recovery prospects hinting at a possible rise in its stock price.
  2. In the realm of finance and investing, accelerating stocks such as Allianz and recovering candidates like BASF, which offer appealing dividends and the potential for growth, make for strategic additions to a 2025 portfolio, providing a diverse mix of momentum and turnaround prospects in the stock-market landscape.

Read also:

    Latest